Pacific Biosciences of California (PACB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Pacific Biosciences of California Revenue Highlights

Latest Revenue (Y)

$200.52M

Latest Revenue (Q)

$38.81M

Main Segment (Y)

Product

Main Geography (Y)

North America

Pacific Biosciences of California Revenue by Period

Pacific Biosciences of California Revenue by Year

Date	Revenue	Change
2023-12-31	$200.52M	56.29%
2022-12-31	$128.30M	-1.69%
2021-12-31	$130.51M	65.43%
2020-12-31	$78.89M	-13.20%
2019-12-31	$90.89M	15.60%
2018-12-31	$78.63M	-15.88%
2017-12-31	$93.47M	3.04%
2016-12-31	$90.71M	-2.23%
2015-12-31	$92.78M	53.12%
2014-12-31	$60.59M	115.02%
2013-12-31	$28.18M	8.46%
2012-12-31	$25.98M	-23.27%
2011-12-31	$33.86M	1922.88%
2010-12-31	$1.67M	1140.00%
2009-12-31	$135.00K	-85.02%
2008-12-31	$901.00K	-58.34%
2007-12-31	$2.16M	-

Pacific Biosciences of California generated $200.52M in revenue during NA 2023, up 56.29% compared to the previous quarter, and up 255.03% compared to the same period a year ago.

Pacific Biosciences of California Revenue by Quarter

Date	Revenue	Change
2024-03-31	$38.81M	-33.50%
2023-12-31	$58.36M	4.79%
2023-09-30	$55.69M	17.06%
2023-06-30	$47.57M	22.30%
2023-03-31	$38.90M	42.21%
2022-12-31	$27.35M	-15.34%
2022-09-30	$32.31M	-8.90%
2022-06-30	$35.47M	6.92%
2022-03-31	$33.17M	-7.90%
2021-12-31	$36.02M	3.24%
2021-09-30	$34.89M	13.97%
2021-06-30	$30.61M	5.56%
2021-03-31	$29.00M	6.86%
2020-12-31	$27.14M	42.21%
2020-09-30	$19.08M	11.74%
2020-06-30	$17.08M	9.48%
2020-03-31	$15.60M	-44.15%
2019-12-31	$27.93M	27.45%
2019-09-30	$21.91M	-10.99%
2019-06-30	$24.62M	49.90%
2019-03-31	$16.43M	-15.88%
2018-12-31	$19.53M	7.52%
2018-09-30	$18.16M	-15.84%
2018-06-30	$21.58M	11.45%
2018-03-31	$19.36M	-22.35%
2017-12-31	$24.93M	5.90%
2017-09-30	$23.55M	17.30%
2017-06-30	$20.07M	-19.43%
2017-03-31	$24.91M	-3.14%
2016-12-31	$25.72M	2.40%
2016-09-30	$25.12M	21.07%
2016-06-30	$20.75M	8.47%
2016-03-31	$19.13M	-47.28%
2015-12-31	$36.28M	160.70%
2015-09-30	$13.92M	-44.20%
2015-06-30	$24.94M	41.34%
2015-03-31	$17.64M	4.38%
2014-12-31	$16.90M	-18.03%
2014-09-30	$20.62M	80.51%
2014-06-30	$11.43M	-1.86%
2014-03-31	$11.64M	27.47%
2013-12-31	$9.13M	23.07%
2013-09-30	$7.42M	22.70%
2013-06-30	$6.05M	8.43%
2013-03-31	$5.58M	-5.10%
2012-12-31	$5.88M	111.74%
2012-09-30	$2.78M	-61.93%
2012-06-30	$7.29M	-27.37%
2012-03-31	$10.04M	-19.33%
2011-12-31	$12.44M	18.30%
2011-09-30	$10.52M	-1.04%
2011-06-30	$10.63M	3837.04%
2011-03-31	$270.00K	-3.57%
2010-12-31	$280.00K	27.27%
2010-09-30	$220.00K	-65.02%
2010-06-30	$629.00K	15.41%
2010-03-31	$545.00K	303.70%
2009-12-31	$135.00K	100.00%
2009-09-30	-	-

Pacific Biosciences of California generated $38.81M in revenue during Q1 2024, up -33.50% compared to the previous quarter, and up 141.89% compared to the same period a year ago.

Pacific Biosciences of California Revenue Breakdown

Pacific Biosciences of California Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Instrument	$48.72M	$61.32M	$34.28M	$45.13M	$28.49M
Product	$108.70M	$113.50M	$65.42M	$77.74M	$66.36M
Service And Other	$19.61M	$17.01M	$13.47M	$13.15M	$12.27M
Consumable	$59.98M	$52.18M	$31.14M	$32.62M	$37.86M

Pacific Biosciences of California's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (45.86%), Consumable (25.31%), Instrument (20.56%), and Service And Other (8.27%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
Consumable	$18.51M	$15.98M	$16.87M	$13.73M	$13.95M	$16.07M	$14.56M	$12.69M	$37.19M	$12.25M	$10.36M	$8.02M	$4.82M	$8.27M	$6.90M	$8.59M	$7.83M	-	-	-
Product	$35.30M	$35.01M	$51.56M	$43.66M	$34.65M	$22.77M	$27.51M	$30.18M	$28.24M	$30.50M	$26.53M	$25.30M	$23.63M	$15.75M	$13.76M	$12.29M	$24.55M	$18.48M	$21.25M	$13.46M
Instrument	$16.79M	$19.02M	$34.69M	$29.92M	$20.70M	$11.44M	$15.62M	$15.55M	$45.15M	$14.28M	$14.94M	$7.73M	$8.93M	$4.02M	$11.58M	$12.66M	$5.62M	-	-	-
Service And Other	$4.67M	$3.80M	$4.13M	$3.92M	$4.25M	$4.58M	$4.80M	$5.29M	$4.93M	$4.38M	$4.08M	$3.69M	$3.51M	$3.33M	$3.32M	$3.31M	$3.38M	$3.43M	$3.37M	$2.97M

Pacific Biosciences of California's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (46.90%), Consumable (24.59%), Instrument (22.31%), and Service And Other (6.21%).

Pacific Biosciences of California Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Europe	$22.60M	$30.27M	$19.07M	$19.60M	$13.96M
North America	$69.56M	$64.52M	$37.28M	$44.68M	$35.60M
Asia Pacific	$36.15M	$35.72M	$22.55M	$26.61M	$29.07M

Pacific Biosciences of California's latest annual revenue breakdown by geography, as of Dec 22: North America (54.22%), Asia Pacific (28.17%), and Europe (17.61%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18	Mar 18
Americas	$20.11M	$17.68M	$28.98M	$23.96M	$19.07M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asia Pacific	$10.74M	$12.78M	$15.72M	$12.88M	$11.96M	$9.57M	$8.01M	$8.39M	$9.17M	$9.77M	$8.52M	$5.77M	$4.43M	$4.44M	$6.58M	$6.99M	$4.37M	$6.29M	$8.69M	$7.60M
EMEA	$9.12M	$8.36M	$10.99M	$10.73M	$7.87M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
North America	-	-	-	-	-	$16.74M	$21.72M	$19.08M	$19.37M	$14.35M	$12.16M	$8.97M	$8.46M	$7.76M	$10.39M	$14.22M	$8.99M	$8.96M	$9.20M	$7.80M
Europe	-	-	-	-	-	$6.00M	$5.74M	$5.70M	$6.35M	$6.49M	$8.32M	$4.34M	$4.19M	$3.40M	$4.94M	$3.41M	$3.06M	$2.91M	$3.69M	$4.00M

Pacific Biosciences of California's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (50.31%), Asia Pacific (26.87%), and EMEA (22.82%).

Pacific Biosciences of California Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CRSP	CRISPR Therapeutics	$370.00M	$602.00K
TWST	Twist Bioscience	$312.97M	$81.46M
PACB	Pacific Biosciences of California	$200.52M	$38.81M
NTLA	Intellia Therapeutics	$36.27M	$9.11M
EDIT	Editas Medicine	-	-

PACB Revenue FAQ

What is Pacific Biosciences of California’s yearly revenue?

Pacific Biosciences of California's yearly revenue for 2023 was $200.52M, representing an increase of 56.29% compared to 2022. The company's yearly revenue for 2022 was $128.3M, representing a decrease of -1.69% compared to 2021. PACB's yearly revenue for 2021 was $130.51M, representing an increase of 65.43% compared to 2020.

What is Pacific Biosciences of California’s quarterly revenue?

Pacific Biosciences of California's quarterly revenue for Q1 2024 was $38.81M, a -33.50% decrease from the previous quarter (Q4 2023), and a -0.23% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $58.36M, a 4.79% increase from the previous quarter (Q3 2023), and a 113.35% increase year-over-year (Q4 2022). PACB's quarterly revenue for Q3 2023 was $55.69M, a 17.06% increase from the previous quarter (Q2 2023), and a 72.36% increase year-over-year (Q3 2022).

What is Pacific Biosciences of California’s revenue growth rate?

Pacific Biosciences of California's revenue growth rate for the last 3 years (2021-2023) was 53.64%, and for the last 5 years (2019-2023) was 120.62%.

What are Pacific Biosciences of California’s revenue streams?

Pacific Biosciences of California's revenue streams in c 22 are Instrument, Product, Service And Other, and Consumable. Instrument generated $48.72M in revenue, accounting 20.56% of the company's total revenue, down -20.55% year-over-year. Product generated $108.7M in revenue, accounting 45.86% of the company's total revenue, down -4.23% year-over-year. Service And Other generated $19.6M in revenue, accounting 8.27% of the company's total revenue, up 15.27% year-over-year. Consumable generated $59.98M in revenue, accounting 25.31% of the company's total revenue, up 14.95% year-over-year.

What is Pacific Biosciences of California’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Pacific Biosciences of California was Product. This segment made a revenue of $108.7M, representing 45.86% of the company's total revenue.